• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa-Gevaert cuts outlook

Article

Sales rose about 9% in the second quarter for Agfa-Gevaert, but the good news may not last. The company warned that profits are falling short of expectations due to higher exceptional expenses and to production and administrative costs. Profits may not

Sales rose about 9% in the second quarter for Agfa-Gevaert, but the good news may not last. The company warned that profits are falling short of expectations due to higher exceptional expenses and to production and administrative costs. Profits may not return to previous levels until sometime next year. Executives expect to release a plan to regain profitability on Sept. 27. The plan will focus on efficiency and cost-effectiveness but will not alter the company’s strategy of further expansion and acquisition in digital imaging.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.